Skip to main content

Gallin and Ognibene's Principles and Practice of Clinical Research

  • 5th Edition - January 1, 2027
  • Latest edition
  • Editors: John I. Gallin, Anne Zajicek, Laura Lee Johnson
  • Language: English

Gallin and Ognibene’s Principles and Practice of Clinical Research, Fifth Edition provides the definitive text on clinical research as written by internationally recognized e… Read more

Back to School

Start strong. Study with purpose.

Save up to 25% on trusted learning resources

Description

Gallin and Ognibene’s Principles and Practice of Clinical Research, Fifth Edition provides the definitive text on clinical research as written by internationally recognized experts from the National Institutes of Health, the US Food and Drug Administration, academia, and global researchers. This new edition contains more than 30 new authors and 9 new chapters. Topics covered emphasize the role of informatics in clinical research, incorporating clinical outcome assessment into endpoints for decision-making, inclusion of diverse and vulnerable research subjects, patient advocacy groups, rare disease research, preparing research for pandemics, public health emergencies, research opportunities for surgeons, and content on preclinical animal studies.

For the international researcher, two new chapters detail international clinical research experiences in South Africa, India, and Pakistan. As with the previous edition, the new release provides readers with summary questions and answers after each chapter.

Key features

  • Study design considerations
  • Statistical concepts relevant to clinical research
  • Patient and community engagement
  • Engagement of patient advocacy and rare disease organizations
  • Preparing for clinical research during public health emergencies
  • Incorporating clinical outcome assessments into endpoints for decision-making
  • Research opportunities for clinical researchers in various medical fields
  • Written and edited by experts in the field and dedicated to facilitating the translation of scientific research from bench to bedside and back

Readership

Investigators involved in clinical research including both students and scientific researchers as well as physicians and members of allied health professions

Table of contents

1. HIV and COVID

2. Ethical Principles in Clinical Research

3. Integrity in Research: Principles for the Conduct of Research

4. Institutional Review Boards

5. Accreditation of Human Research Protection Programs

6. The Regulation of Drugs and Devices by the Food and Drug Administration

7. International Regulation of Drugs, Devices and Biologic Products

8. Clinical Research in International Settings: The India and Pakistan Experience

9. Clinical Research in International Settings: The South African Experience

10. The Role and Importance of Clinical Trial Registries

11. Data and Safety Monitoring

12. Unanticipated Risk in Clinical Research

13. Legal Issues in Clinical Research

14. NIH Policy on the Inclusion of Women and Minorities and Diversity, Equity, Inclusion, and Accommodation in Clinical Research

15. Vulnerable Populations

16. Clinical Research: A Patient Perspective

17. Patient Advocacy Groups and Rare Disease Research

18. Development and Conduct of Studies

19. Writing a Protocol

20. Master Protocols

21. Design of Observational Studies

22. Design of Clinical Trials and Studies

23. Role of Comparative Effectiveness Research

24. Using Large Data Sets for Population Based Health Research

25.Cha Measures of Function and Health related Quality of Life

26. Incorporating Clinical Outcome Assessment into Endpoints for Decision Making

27. Meta-Analysis of Clinical Trials

28. Issues of Randomization

29. Hypothesis Testing

30. Power and Sample Size Calculations

31. An Introduction to Survival Analysis

32. Advanced Topics in Biostatistics

33. Large Clinical Trials--Registries. Clinical Research Institutes

34. Special Challenges Facing the Clinical Investigator Conducting a Clinical Trial from Start to Finish. The Meropoenem experience

35. Intellectual Property and Technology Transfer

36. Clinical Research Data: Characteristics, Representation, Storage and Retrieval

37. Data Management in Clinical Trials

38. Importance and use of Electronic Health Records

39. Management of Patient Samples

40. Evaluating a Protocol Budget

41. Getting the Funding you Need to Support your Research. Navigating the National Institutes of Health Peer Review Process

42. Philanthropy’s Role in Advancing Biomedical Research

43. Preclinical animal studies

44. Clinical Pharmacology and Its Role in Pharmaceutical Development

45. Identifying, Understanding and Management of Patient Safety and Clinical Risks

46. Career Paths in Clinical Research

47. Opportunities for Surgeons in Clinical Research

48. Clinical Research Nursing

49. Preparing for the Next Pandemic/Emergency Preparedness

50. Clinical Research and the Media

51. Information Resources for the Clinical Researcher

Product details

  • Edition: 5
  • Latest edition
  • Published: January 1, 2027
  • Language: English

About the editors

JG

John I. Gallin

Dr.John Gallin served as Director of the NIH Clinical Center (1994–2017) and later as NIH Associate Director for Clinical Research. He led the development of the Mark O. Hatfield Clinical Research Center and global training programs. His research focused on rare immune disorders, and he published extensively. Dr. Gallin was the founder of the Introduction to the Principles and Practice of Clinical Research course at the NIH. Dr. Gallin passed away in 2024.

Affiliations and expertise
Chief Scientific Officer, Clinical Center, Associate Director for Clinical Research, National Institutes of Health, Bethesda, MD, USA

AZ

Anne Zajicek

Dr. Anne Zajicek is a pediatrician and clinical pharmacologist who directed the Office of Clinical Research Education and Collaboration Outreach at NIH. She previously held leadership roles at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, focusing on pediatric and obstetric pharmacology and research training.

Affiliations and expertise
National Institute of Health, Maryland, USA

LJ

Laura Lee Johnson

Laura Lee Johnson is a Division Director for the Office of Biostatistics at the FDA’s Center for Drug Evaluation and Research. She specializes in study design and endpoint development and spent over a decade at NIH overseeing clinical research programs.

Affiliations and expertise
Associate Director, Division of Biometrics III, FDA/CDER Office of Biostatistics, Silver Spring, MD, USA